NovoCure Long Term Debt 2014-2023 | NVCR
NovoCure long term debt from 2014 to 2023. Long term debt can be defined as the sum of all long term debt fields.
| NovoCure Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $569 |
| 2022 | $566 |
| 2021 | $562 |
| 2020 | $430 |
| 2019 | $149 |
| 2018 | $149 |
| 2017 | $97 |
| 2016 | $96 |
| 2015 | $23 |
| 2014 | $ |
| 2013 | $ |
| NovoCure Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2023-12-31 | $569 |
| 2023-09-30 | $568 |
| 2023-06-30 | $567 |
| 2023-03-31 | $566 |
| 2022-12-31 | $566 |
| 2022-09-30 | $565 |
| 2022-06-30 | $564 |
| 2022-03-31 | $563 |
| 2021-12-31 | $562 |
| 2021-09-30 | $561 |
| 2021-06-30 | $561 |
| 2021-03-31 | $560 |
| 2020-12-31 | $430 |
| 2020-09-30 | |
| 2020-06-30 | $150 |
| 2020-03-31 | $149 |
| 2019-12-31 | $149 |
| 2019-09-30 | $149 |
| 2019-06-30 | $149 |
| 2019-03-31 | $149 |
| 2018-12-31 | $149 |
| 2018-09-30 | $149 |
| 2018-06-30 | $149 |
| 2018-03-31 | $149 |
| 2017-12-31 | $97 |
| 2017-09-30 | $97 |
| 2017-06-30 | $97 |
| 2017-03-31 | $96 |
| 2016-12-31 | $96 |
| 2016-09-30 | $96 |
| 2016-06-30 | $23 |
| 2016-03-31 | $23 |
| 2015-12-31 | $23 |
| 2015-09-30 | $25 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.371B | $0.509B |
| NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.982B | 15.31 |
| Cencora (COR) | United States | $45.721B | 17.82 |
| ICON (ICLR) | Ireland | $24.881B | 23.49 |
| DiDi Global (DIDIY) | China | $23.865B | 0.00 |
| Avantor (AVTR) | United States | $16.588B | 24.42 |
| Viatris (VTRS) | United States | $13.847B | 3.98 |
| CochLear (CHEOY) | Australia | $13.505B | 0.00 |
| Revvity (RVTY) | United States | $12.674B | 22.21 |
| Medpace Holdings (MEDP) | United States | $12.327B | 40.56 |
| Charles River Laboratories (CRL) | United States | $11.986B | 21.85 |
| Natera (NTRA) | United States | $11.509B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.385B | 0.00 |
| Solventum (SOLV) | United States | $11.239B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| HealthEquity (HQY) | United States | $6.843B | 51.12 |
| Organon (OGN) | United States | $4.843B | 4.66 |
| Bausch + Lomb (BLCO) | Canada | $4.828B | 19.35 |
| Doximity (DOCS) | United States | $4.479B | 33.35 |
| PACS (PACS) | United States | $3.736B | 0.00 |
| Sotera Health (SHC) | United States | $3.190B | 15.65 |
| Surgery Partners (SGRY) | United States | $3.131B | 28.98 |
| Progyny (PGNY) | United States | $3.103B | 52.08 |
| GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
| Life Times (LTH) | United States | $2.557B | 27.08 |
| Premier (PINC) | United States | $2.523B | 9.24 |
| AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| Agilon Health (AGL) | United States | $2.039B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.825B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.390B | 0.00 | |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Alignment Healthcare (ALHC) | United States | $0.995B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.757B | 7.83 |
| Embecta (EMBC) | United States | $0.583B | 3.85 |
| GeneDx Holdings (WGS) | United States | $0.545B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.525B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.517B | 0.00 |
| Enhabit (EHAB) | United States | $0.511B | 46.27 |
| LifeMD (LFMD) | United States | $0.476B | 0.00 |
| CareDx (CDNA) | United States | $0.475B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
| MultiPlan (MPLN) | United States | $0.414B | 0.00 |
| Beauty Health (SKIN) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.353B | 56.50 |
| Sera Prognostics (SERA) | United States | $0.338B | 0.00 |
| ModivCare (MODV) | United States | $0.317B | 4.20 |
| Sharecare (SHCR) | United States | $0.263B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Biodesix (BDSX) | United States | $0.143B | 0.00 |
| So-Young (SY) | China | $0.127B | 42.67 |
| Oncology Institute (TOI) | United States | $0.083B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| OpGen (OPGN) | United States | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |